Unveiling the experimental proof of the anticancer potential of ginsenoside Rg3 (Review)

Oncol Lett. 2024 Feb 28;27(4):182. doi: 10.3892/ol.2024.14315. eCollection 2024 Apr.ABSTRACTGinsenoside Rg3 (GS-Rg3), a sterol molecule isolated from ginseng, has demonstrated various immunological properties, including inhibition of cancer cell proliferation and metastasis, reversal of drug resistance and enhancement of chemotherapy sensitivity. The recent surge in attention towards GS-Rg3 can be attributed to its potential as an antitumor angiogenesis agent and as a therapeutic candidate for immunotherapy. The development of GS-Rg3 as an agent for these purposes has accelerated research on its mechanisms of action. The present review summarizes recent studies investigating the antitumor activity of GS-Rg3 and its underlying mechanisms, as well as providing essential information for future studies on GS-Rg3.PMID:38476209 | PMC:PMC10928969 | DOI:10.3892/ol.2024.14315
Source: Oncology Letters - Category: Cancer & Oncology Authors: Source Type: research